Thomas Gurry

Following a bachelors in Biochemistry and masters in Computational Biology, Thomas completed a PhD in Computational and Systems Biology at MIT. As a postdoc, also at MIT, he began studying the clinical impact of the gut microbiome with Prof. Eric Alm at the MIT Center for Microbiome Informatics and Therapeutics. It was during this time that he developed an interest in how we can use dietary interventions to shape the composition and metabolic output of the microbiome for therapeutic purposes. This led him to work on building a framework around personalised dietary fibre supplementation aiming to boost Short Chain Fatty Acid (SCFA) production in the gut. Thanks to the support of Seerave, Thomas has launched a clinical trial investigating the impact of different diets on plasma SCFAs and circulating markers of inflammation.

  • Diet and the gut microbiome
  • Short Chain Fatty Acids
  • Machine learning